[Reversible thrombopenia in the clinical use of antilymphocyte serum].
D000371:Agglutination; D000961:Antilymphocyte Serum / Q000009:adverse effects* / Q000494:pharmacology; D001792:Blood Platelets; D002859:Chromium Isotopes; D006801:Humans; D007700:Kinetics; D008099:Liver; D008214:Lymphocytes / Q000378:metabolism; D014066:Palatine Tonsil; D013154:Spleen; D013921:Thrombocytopenia / Q000139:chemically induced*
D000961:Antilymphocyte Serum; D002859:Chromium Isotopes
Reversible Thrombopenie bei klinischer Anwendung von Antilymphocytenserum.